Cardiac resynchronization therapy in non-ischemic cardiomyopathy: a comparative non-randomized study of His Bundle pacing versus biventricular pacing

医学 心脏再同步化治疗 心脏病学 射血分数 内科学 左束支阻滞 心力衰竭 四分位间距 QRS波群 心肌病 缺血性心肌病 冠状窦
作者
Pablo Moriña‐Vázquez,María Teresa Moraleda Salas,Adrián Rodríguez-Albarrán,Álvaro Arce‐León,José Venegas‐Gamero,Juan Manuel Fernández-Gómez,Irene Esteve‐Ruiz,Rafael Barba-Pichardo
出处
期刊:Journal of Interventional Cardiac Electrophysiology [Springer Science+Business Media]
卷期号:66 (5): 1077-1084 被引量:9
标识
DOI:10.1007/s10840-022-01192-2
摘要

Cardiac resynchronization therapy (CRT) via permanent His bundle pacing (pHBP) has gained acceptance globally, but robust studies comparing pHBP-CRT with classic CRT are lacking. In this study, we aimed to compare the improvement in left ventricular ejection fraction (LVEF) after pHBP-CRT versus classic CRT.This was a single-center study comparing a prospective series of pHBP-CRT with a historical series of CRT via classic biventricular pacing (BVP). Patients with non-ischemic cardiomyopathy, baseline LVEF < 35%, left bundle branch block (LBBB), and CRT indications were selected.Fifty-one patients underwent classic CRT and 52 patients underwent pHBP-CRT. In the classic CRT group, the median (interquartile range) basal LVEF was 30% (IQR, 29-35%) before implantation and 40% (35-48%) at follow-up. In the pHBP-CRT group, the median basal LVEF was 30% (28-34%) before implantation and 55% (45-60%) at follow-up, with significant differences between both modalities at follow-up (p = 0.001). The median long term His recruitment threshold with LBBB correction was 1.25 (1-2.5) V at 0.4 ms in cases of pHBP-CRT, compared to a left ventricular coronary sinus threshold of 1.25 (1-1.75) V in cases of classic CRT (p = 0.48). After CRT, the median paced QRS was 135 (120-145) ms for pHBP-CRT versus 140 (130-150) ms for BVP-CRT (p = 0.586).The improvement in LVEF was superior with pHBP-CRT than with classic CRT. The thresholds at follow-up were similar in both groups.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
珍兮完成签到,获得积分10
刚刚
刚刚
1秒前
kuuk发布了新的文献求助30
1秒前
2秒前
2秒前
852应助ys采纳,获得10
3秒前
3秒前
郭自同完成签到,获得积分10
4秒前
852应助李胜采纳,获得10
4秒前
xiuxiu酱完成签到 ,获得积分10
4秒前
5秒前
司空晓山发布了新的文献求助10
5秒前
蓝羽发布了新的文献求助10
6秒前
Maggie完成签到,获得积分10
6秒前
6秒前
张真源发布了新的文献求助10
7秒前
kk发布了新的文献求助10
7秒前
7秒前
7秒前
8秒前
蓝羽完成签到,获得积分10
10秒前
10秒前
平常如天发布了新的文献求助10
12秒前
胖子张发布了新的文献求助10
13秒前
咕噜噜发布了新的文献求助10
13秒前
乐乐应助米饭杀手采纳,获得10
14秒前
海山应助科研通管家采纳,获得10
15秒前
完美世界应助WW采纳,获得10
15秒前
香蕉觅云应助科研通管家采纳,获得10
15秒前
wanci应助整齐冷雪采纳,获得10
15秒前
海山应助科研通管家采纳,获得10
15秒前
15秒前
领导范儿应助正月初九采纳,获得10
15秒前
搜集达人应助科研通管家采纳,获得10
15秒前
youyouzi完成签到,获得积分10
15秒前
CodeCraft应助RC_Wang采纳,获得10
16秒前
在水一方应助科研通管家采纳,获得10
16秒前
墨绾菩提应助科研通管家采纳,获得10
16秒前
CipherSage应助科研通管家采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6963608
求助须知:如何正确求助?哪些是违规求助? 8645748
关于积分的说明 18336534
捐赠科研通 6414101
什么是DOI,文献DOI怎么找? 3086867
关于科研通互助平台的介绍 2136295
邀请新用户注册赠送积分活动 2063311